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Untreated staghorn calculi can cause xanthogranulomatous pyelonephritis (XGP), diminished renal
function, and renal malignancy. Squamous cell carcinoma (SCC) of the upper urinary tract is associated
with kidney stones and chronic infection, but their association with transitional cell carcinoma (TCC) has
not been proven and has rarely been reported in literature. We present a rare case of staghorn calculi and
XGP associated with TCC.
Copyright © 2015, Taiwan Urological Association. Published by Elsevier Taiwan LLC.
Open access under CC BY-NC-ND license.1. Introduction
Staghorn calculi are large and branched stones that can ﬁll an
entire renal calyceal system. Persistent chronic irritation and/or
infection by the staghorn calculi can cause xanthogranulomatous
pyelonephritis (XGP), diminished renal function, or renal malig-
nancy.1,2 The most common type of cancer associated with stag-
horn calculi is squamous cell carcinoma (SCC), with a varying
incidence of 18e100%,3,4 followed by the rarely reported transi-
tional cell carcinoma (TCC). TCC of the upper urinary tract is uni-
formly fatal unless it is treated appropriately. In a multicenter study
of 10,355 patients with TCC, the 5-year cancer-speciﬁc survival rate
was approximately 54%.5 TCC has a recurrence rate of 50% in the
bladder6 and a high metastases rate up to 75% in the lymph nodes.7
Thus, early and proper management of TCC is essential for patient
survival.
Here, we report an extremely rare case of a patient who had
staghorn calculi and XGP associated with TCC.tment of Surgery, Shin-Kong
oad, Shih Lin District, Taipei
wang).
ciation. Published by Elsevier Taiw2. Case Report
A 75-year-old female presented with dysuria, high urination
frequency, and right ﬂank pain for 5 days. She had a 4-year history
of medically controlled hypertension and Stage 3 chronic kidney
disease as a comorbid condition. Her family history and physical
examination were noncontributory. She had not undergone any
surgical procedures the previous day. The urine analysis showed
microscopic hematuria and 3þ proteinuria, and urine culture
revealed the presence of Escherichia coli. Hemoglobin was 7.7 g/dL
and leukocytosis with a left shift was noted. Urine cytology showed
no abnormal cells. Renal ultrasound showed a staghorn calculus in
the right kidney (Fig. 1A). Furthermore, the diethylene-triamine
penta-acetic acid renal scan revealed nonfunction of the right
kidney, contributed for only 10% total renal function.
An intravenous urogram was not performed due to azotemia
with a serum creatinine level of 2.5 mg/dL. A high amount of
purulent ﬂuid coming out from the ureteral catheter was noted
during a retrograde pyelogram. A double-J stent was inserted.
After conservative treatment involving blood transfusion, hydra-
tion, and antibiotic administration, the patient underwent right
nephrectomy. The specimen was removed smoothly without
disruption.an LLC. Open access under CC BY-NC-ND license.
Fig. 1. (A) Kidney-ureter-bladder X-ray showing a right staghorn stone; (B) gross
appearance of the right kidney, measuring 13 cm  10 cm  8 cm. Multiple stones
(arrows) were noted in the renal pelvis and calyces with marked dilatation of the
collecting system in the coronal cut surface. A polypoid and cauliﬂower-like tumor
(arrowhead) measuring approximately 3 cm  3 cm  2 cm in size was observed at the
lower pole of the kidney. The upper part of the dilated collecting system is ﬁlled with
purulent debris and surrounded by yellowish fatty tissue (asterisks), corresponding to
xanthogranulomatous inﬂammation; and (C) magniﬁed image of the cauliﬂower-like
tumor shown in Fig. 1B.
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13 cm  10 cm  8 cm, was dark colored and was easily dissected
(Fig. 1B and C). Multiple stones were noted in the renal pelvis and
calyceswithmarked dilatation of the collecting system in the coronal
cut surface. A polypoid and cauliﬂower-like tumor measuring
approximately 3 cm 3 cm 2 cm in sizewas observed at the lower
poleof the kidney. Theupper partof thedilated collecting systemwas
ﬁlled with purulent debris and surrounded by yellowish fatty tissue
corresponding to xanthogranulomatous inﬂammation. The histopa-
thology demonstrated high-grade (World Health Organization,2004) papillary TCC with inﬁltration into the renal pelvis wall and
medulla. Nests of inﬁltrating transitional cells with enlarged, hyper-
chromatic nuclei and pleomorphism were observed. No inﬁltration
was noted in the renal cortex, hilar lymph nodes, adrenal gland, or
ureter (Fig. 2). XGP presented as ﬁbrous background, cholesterol
clefts, and granulomatous inﬂammatory inﬁltrate with lymphoid
germinal center formation. No SCC was found in the resected spec-
imen. No carcinoma was present at the ureteral resection margin.
The patient refused further surgical treatment by ureterectomy
with a bladder cuff and further alternative treatment, such as
chemotherapy. Postoperative chest X-ray, technetium-99m whole
body bone scan, and pelvis-abdominal computed tomography (CT)
showed no evidence of metastasis. Pathological Tumor-Node-
Metastasis staging was Stage 3 (pT3N0M0).
Nine months later, the patient was readmitted with symptoms
of right upper quadrant pain, abdominal fullness, nausea, vomiting,
and yellowish skin lasting for 5 days. Abdominal ultrasound
showed multiple metastatic tumors over the right lobe of the liver.
Furthermore, abdominal CT revealed multiple nodal metastasis and
tumor implantations in the duodenum, retrocaval space, right he-
patic surface, peritoneal space, remnant right ureter stump, and
urinary bladder. Endoscopic retrograde cholangiopancreatography
(ERCP) showed deformity of the duodenal bulb and obstruction of
the ﬁrst portion of duodenum by a tumor. Biopsies showed meta-
static urothelial carcinoma. Because the ERCP procedure was
incomplete, percutaneous transhepatic cholangiography and
drainage were performed to relieve the biliary obstruction. Further
surgical treatment involving right ureterectomy and transurethral
resection of the bladder tumor was performed, and histological
analysis revealed recurrent high-grade papillary TCC. Four cycles of
postoperative palliative gemcitabine chemotherapy were planned,
but the patient expired 10 days after surgery due to severe, pro-
gressive hepatic encephalopathy.
3. Discussion
Staghorn calculi are primarily composed of a mixture of mag-
nesium ammonium phosphate (struvite) and calcium carbonate
apatite that is produced by urea-splitting organisms such as Pro-
teus, Klebsiella, Pseudomonas, and Staphylococcus species. If left
untreated, such stones can result in deterioration of renal function,
XGP, life-threatening urosepsis, or even renal malignancies.1,2
Several aspects of this case are unique. First, the patient had a
rare combination of complete staghorn calculi, XGP, and TCC of the
renal pelvis. XGP is an uncommon, aggressive inﬂammation of the
renal parenchyma that may occur in the presence of chronic
obstruction or infection.7 Renal calculi, frequently of the staghorn
type, have been reported in 47e100% of cases with XGP.7 The as-
sociation between XGP and renal malignancy is rarely described in
literature. One case of a patient with XGP and TCC of the renal pelvis
was previously reported, but without the presence of urolithiasis.7
Long-standing staghorn calculi are associated with TCC.4 Chronic,
mechanical irritation by staghorn calculi may result in squamous
metaplasia,which subsequently develops into SCC. The cause of TCC
with the presence of staghorn calculi remains unclear. However,
several studies have provided evidence that TCC is associated with
urinary calculi. In a prospective cohort study, patients with kidney
or ureteral stones were observed for renal pelvic/ureteral cancer.8
The gold standard procedure for TCC of the renal pelvis is
nephroureterectomy with bladder cuff excision. However, our pa-
tient refused this recommendation and did not return to our
outpatient department until 9 months later.
The present case is also unique because TCC of the renal pelvis
metastasized to the duodenum, which caused obstruction of the
biliary tract causing jaundice. According to Shinagare et al,9 in the
Fig. 2. (A) Photomicrograph showing areas of invasive, papillary transitional cell carcinomawith extension to the full depth of the renal parenchyma [hematoxylin and eosin (H&E),
40]; (B) note nests of inﬁltrating transitional cells with enlarged, hyperchromatic nuclei and pleomorphism (H&E, 400); (C) xanthogranulomatous pyelonephritis (XGP) pre-
senting as ﬁbrous background, cholesterol clefts, and granulomatous inﬂammatory inﬁltrate with lymphoid germinal center formation (H&E, 100); and (D) XGP showed char-
acteristic lipid-laden foamy macrophages or xanthoma cells (H&E, 400).
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lymph nodes were the most common site of metastasis (75%), fol-
lowed by the lung (65%), liver (54%), bone (39%), peritoneum (19%),
pleura (15%), soft tissue (15%), adrenal gland (14%), and brain (8%).
Here we stress the importance of radiological survey of the
gastrointestinal tract in patients with upper urinary tract TCC.
The prevalence of carcinoma associated with kidney stones
causing loss of kidney function remains unclear. A high incidence of
malignancy, including 17 cases of TCC, ﬁve cases of renal carcinoma,
one case of SCC, and one case of epidermoid carcinoma, was
observed in 24 of 47 (51%) patients diagnosed with a nonfunc-
tioning kidney caused by kidney stones, who underwent ne-
phrectomy, as reported by Yeh et al10; this suggests the importance
of careful pathological evaluation of surgical specimens to evaluate
the necessity of performing a more invasive surgery such as
nephroureterectomy. Moreover, the possibility of upper urinary
tract malignancy in patients with XGP and a nonfunctioning kidney
should be considered. Preoperative noncontrast CT may be helpful
for evaluating the possibility of malignancy.4 A frozen biopsy
collected intraoperatively is also advised for evaluating whether
nephroureterectomy with bladder cuff excision is necessary.
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